More about

Insulin Delivery

News
November 29, 2021
4 min read
Save

Consensus group: Providers, policies must support DIY artificial pancreas use

Consensus group: Providers, policies must support DIY artificial pancreas use

Health care providers should facilitate and support people with diabetes who choose to use a do-it-yourself automated insulin delivery system, working together with patients to set “realistic” goals and minimize any hypoglycemia risk.

News
May 24, 2021
3 min read
Save

‘Loop’ artificial pancreas software safe, effective with community support

‘Loop’ artificial pancreas software safe, effective with community support

The Loop open-source system for a do-it-yourself automated insulin delivery system can be initiated with community-developed resources and used safely and effectively by adults and children with type 1 diabetes, real-world data show.

News
February 24, 2021
2 min read
Save

Inhaled insulin reduces HbA1c, body weight in 24-week trial

Inhaled insulin reduces HbA1c, body weight in 24-week trial

Among adults with type 2 diabetes, inhaled insulin was associated with HbA1c reductions similar to those with insulin aspart, fewer hypoglycemic episodes and lower body weight, according to a study published in Endocrine Practice.

News
February 11, 2021
2 min read
Save

Bihormonal artificial pancreas system improves time in range, reduces hypoglycemia

Bihormonal artificial pancreas system improves time in range, reduces hypoglycemia

Adults with type 1 diabetes using a fully closed-loop, bihormonal artificial pancreas experienced improved glucose response compared with insulin pump therapy without the need to provide meal or exercise announcements, outpatient data show.

News
February 02, 2021
4 min read
Save

Artificial pancreas may be safe for young children with type 1 diabetes

Artificial pancreas may be safe for young children with type 1 diabetes

A modified version of an FDA-approved close-loop insulin delivery system may be effective for children aged 2 to 5 years with type 1 diabetes, according to study data published in Diabetes Technology & Therapeutics.

News
October 05, 2020
3 min read
Save

Smart insulin pens address challenges of multiple daily injection therapy

Smart insulin pens address challenges of multiple daily injection therapy

In this issue, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with nurse practitioner and diabetes care and education specialist Colleen Miller-Owen, MSN, APRN, CDCES, about the benefits of smart insulin pens for multiple daily injections.

News
September 01, 2020
3 min read
Save

FDA approves artificial pancreas for young children with type 1 diabetes

FDA approves artificial pancreas for young children with type 1 diabetes

The FDA approved a next-generation hybrid closed-loop insulin delivery system for children aged 2 to 6 years with type 1 diabetes, according to an agency press release.

News
August 16, 2020
5 min read
Save

Educator support facilitates safe use of do-it-yourself artificial pancreas

Educator support facilitates safe use of do-it-yourself artificial pancreas

People with diabetes who use a “hacked” hybrid closed-loop insulin delivery system continue to need clinical support to create initial settings, adjust settings over time and ensure such settings promote safety, according to a speaker.

News
June 18, 2020
2 min read
Save

FDA clears interoperable insulin pump for pediatric use

The FDA cleared an expanded pediatric indication for the t:slim X2 interoperable insulin pump, lowering its indicated age for use in children from age 14 years to age 6 years, according to a press release from Tandem.

News
June 13, 2020
3 min read
Save

Next-generation artificial pancreas ‘user-friendly’ option for teens with type 1 diabetes

Next-generation artificial pancreas ‘user-friendly’ option for teens with type 1 diabetes

Adolescents and young adults with type 1 diabetes who used a next-generation hybrid closed-loop insulin delivery system saw improvements in HbA1c and time-in-range with no increase in hypoglycemia, study data show.

View more